Filing Details

Accession Number:
0001127602-10-014629
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-18 13:00:00
Reporting Period:
2010-05-14
Filing Date:
2010-05-18
Accepted Time:
2010-05-18 13:36:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
912183 Cubist Pharmaceuticals Inc CBST Pharmaceutical Preparations (2834) 223192085
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1386932 Santosh Vetticaden 65 Hayden Avenue
Lexington MA 02421
Svp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-15 2,237 $0.00 3,539 No 4 M Direct
Common Stock Disposition 2010-05-17 927 $21.81 2,612 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2010-05-14 7,500 $0.00 7,500 $0.00
Common Stock Stock Options (Right to Buy) Acquisiton 2010-05-14 35,000 $0.00 35,000 $21.56
Common Stock Restricted Stock Units Disposition 2010-05-15 2,237 $0.00 2,237 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,500 2011-05-14 No 4 A Direct
35,000 2010-08-14 2020-05-14 No 4 A Direct
6,712 2010-05-15 No 4 M Direct
Footnotes
  1. Represents the sale of a portion of the shares underlying the Restricted Stock Units that vested on May 15, 2010 in order to cover the reporting person's tax obligations that resulted from such vesting.
  2. This transaction was executed in multiple trades at prices ranging from $21.80 to $21.83. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Each restricted stock unit represents a contingent right to receive one share of Cubist common stock.
  4. The restricted stock units vest 25% annually over a four-year period, with the first 25% vesting one year after the grant date. The restricted stock units do not expire.
  5. Option vests 6.25% quarterly over a four-year period.